Intellectual Property

Recognized as Law360’s 2023 Intellectual Property Practice Group of the Year, our team has a strong track record of enforcing and defending patent rights in the life sciences industry. With a primary focus on litigation and trial excellence, much of our life sciences IP work involves our clients’ blockbuster products. Our areas of focus include:

• Extensive patent and commercial litigation representation, including Hatch-Waxman and BPCIA matters, and medical device and diagnostics litigation
• International Trade Commission (ITC) Investigations, Post-Grant proceedings (IPRs and PGRs), and ex parte reexamination
• Integrated patent/regulatory exclusivity advice
• Coordinated patent/antitrust counseling
• Patent procurement and prosecution across a variety of industries, including biologics, biotechnology, medical equipment, microfluidics, nanotechnology, and pharmaceuticals, among others
• Trademark prosecution, counseling and enforcement matters, domain name disputes, and related matters